Cost-effectiveness of paramedic-administered prehospital thrombolysis for ST elevation myocardial infarction
Year: 2026
Type: article
Abstract: Guidelines recommend prehospital thrombolysis for ST-segment elevation myocardial infarction (STEMI) if trained clinicians can interpret 12-lead electrocardiogram (ECG) on site. The Queensland Ambulance Service (QAS) has a well-established prehospital reperfusion program under which all paramedics are trained in prehospital STEMI diagnosis on 12-lead ECG and administering thrombolysis in the field to eligible patients. Whilst the clinical benefits of this treatment are proven, its cost-effectiveness remains to be established. We developed a decision-analytic microsimulation model to evaluate the cost-effectiveness of paramedic-administered thrombolysis for prehospital STEMI in the state of Queensland, Australia. The comparator was a hypothetical counterfactual group of patients who were clinically eligible for prehospital thrombolysis but received an alternate treatment pathway. The analysis was conducted from a health provider (Queensland Government) perspective. A lifetime time horizon was used. Input values of the acute phase were derived from our prehospital and linked hospital database of all STEMI patients receiving prehospital thrombolysis from QAS paramedics between January 2022 and December 2024. Input values of the long-term phase were obtained from published literature. Cost was expressed in Australian dollars (AUD) and United States dollars (USD) in 2026 value, and effectiveness in quality-adjusted life years (QALYs). Prehospital thrombolysis improved outcomes at a cost of AUD 16,750.22 per QALY gained (95% uncertainty range AUD 15,477.48 – 18,422.84) or USD 11,725.15 (USD 10,834.24 – 12,895.99). In the sensitivity analysis, the cost-effectiveness of prehospital thrombolysis was robust to changes in input values. Paramedic-administered thrombolysis in the field for prehospital STEMI, compared with no such treatment, represents value for money.
Source: Figshare
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7234315177
